AUSTIN, TX — Republican Governor Greg Abbott has signed legislation into law expanding the pool of patents eligible to receive low-THC/high-CBD medical cannabis products in Texas.
House Bill 3703 permits those patients diagnosed with autism, amyotrophic lateral sclerosis (aka Lou Gehrig’s disease), multiple sclerosis, seizure disorders, incurable neurodegenerative disorders and/or terminal cancer to be eligible to register in the state’s limited cannabis access program. The measure also removes the requirement that patients obtain recommendations from two participating physicians prior to enrolling in the program.
The new law takes effect on September 1, 2019.
Tags: Amyotrophic Lateral Sclerosis, autism, incurable neurodegenerative disorders, multiple sclerosis, seizure disorders, Terminal Cancer, TX HB 3703